Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun;58(6):3157-61.
doi: 10.1128/AAC.01924-13. Epub 2014 Mar 24.

Laboratory detection of artemisinin-resistant Plasmodium falciparum

Affiliations

Laboratory detection of artemisinin-resistant Plasmodium falciparum

Kesinee Chotivanich et al. Antimicrob Agents Chemother. 2014 Jun.

Abstract

Conventional 48-h in vitro susceptibility tests have low sensitivity in identifying artemisinin-resistant Plasmodium falciparum, defined phenotypically by low in vivo parasite clearance rates. We hypothesized originally that this discrepancy was explained by a loss of ring-stage susceptibility and so developed a simple field-adapted 24-h trophozoite maturation inhibition (TMI) assay focusing on the ring stage and compared it to the standard 48-h schizont maturation inhibition (WHO) test. In Pailin, western Cambodia, where artemisinin-resistant P. falciparum is prevalent, the TMI test mean (95% confidence interval) 50% inhibitory concentration (IC50) for artesunate was 6.8 (5.2 to 8.3) ng/ml compared with 1.5 (1.2 to 1.8) ng/ml for the standard 48-h WHO test (P = 0.001). TMI IC50s correlated significantly with the in vivo responses to artesunate (parasite clearance time [r = 0.44, P = 0.001] and parasite clearance half-life [r = 0.46, P = 0.001]), whereas the standard 48-h test values did not. On continuous culture of two resistant isolates, the artemisinin-resistant phenotype was lost after 6 weeks (IC50s fell from 10 and 12 ng/ml to 2.7 and 3 ng/ml, respectively). Slow parasite clearance in falciparum malaria in western Cambodia results from reduced ring-stage susceptibility.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Correlation between 50% inhibitory concentration (IC50) from TMI test and in vivo responses. (A) IC50 plotted against parasite clearance time (PCT) for the first of two consecutive negative blood films; (B) IC50 plotted against parasite clearance half-life.
FIG 2
FIG 2
Correlation between 50% inhibitory concentration (IC50) from WHO test and in vivo responses. (A) IC50 plotted against parasite clearance time (PCT) for the first of two consecutive negative blood films; (B) IC50 plotted against parasite clearance half-life.
FIG 3
FIG 3
Stability of resistant phenotype. Data are presented as means and standard deviations (SD).

References

    1. World Health Organization. 2010. Guidelines for the treatment of malaria, 2nd ed, p 13–47 WC 770. World Health Organization Press, Geneva, Switzerland
    1. Hien TT, White NJ. 1993. Qinghaosu. Lancet 341:603–608. 10.1016/0140-6736(93)90362-K - DOI - PubMed
    1. White NJ. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330–334. 10.1126/science.1155165 - DOI - PubMed
    1. Ashley EA, White NJ. 2005. Artemisinin-based combinations. Curr. Opin. Infect. Dis. 18:531–536. 10.1097/01.qco.0000186848.46417.6c - DOI - PubMed
    1. Nosten F, White NJ. 2007. Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg. 77(6 Suppl):181–192 - PubMed

Publication types

LinkOut - more resources